Author,Title,Journal,ISSN,Publisher,Date,Volume,Number,Page,URL,URL(DOI)
DIERAS V,"Is erbB-2 a predictive marker for response to primary chemotherapy (CT) for operable breast cancer? Prospective study in a phase III randomized, parallel study of doxorubicin/cyclophosphamide (AC) and doxorubicin/Taxol^( !R)(paclitaxel) (AT)",Proc Am Soc Clin Oncol,,,1999,18,,85a,https://cir.nii.ac.jp/crid/1570572700618300672,